Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7442-7451
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7442
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7442
Figure 5 Occludin and zona occludens-1 mRNA expression after heterotopic intestinal transplantation.
Occludin and zona occludens (ZO)-1 mRNA expression was significantly lower in group B than in group A (aP < 0.05 vs group B at day 5: 0.3135 ± 0.0168 vs 0.7011 ± 0.0128; aP < 0.05 vs group B at day 7: 0.2101 ± 0.0279 vs 0.5345 ± 0.0136). Occludin and ZO-1 mRNA expression was significantly higher in group C than in group B at day 5 (aP < 0.05 vs group B at day 7: 0.3860 ± 0.0254 vs 0.1673 ± 0.0369; aP < 0.05 vs group B at day 5: 0.5727 ± 0.0419 vs 0.3598 ± 0.0242). A: Group A (non-rejection); B: Group B (rejection); C: Group C (bone marrow mesenchymal stem cells therapy). β-actin was used as the loading control. Values shown are the mean ± SD.
- Citation: Zhang W, Shen ZY, Song HL, Yang Y, Wu BJ, Fu NN, Liu T. Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation. World J Gastroenterol 2014; 20(23): 7442-7451
- URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7442.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7442